Home › Companies › AURINIA PHARMACEUTICALS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and AURINIA PHARMACEUTICALS INC.’s Form 8-K, filed June 14, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 14, 2024: 12 items on AURINIA PHARMACEUTICALS INC.’s Form 8-K, filed June 14, 2024: 1 approved · 5 passed (calculated) · 2 not approved · 4 plurality election.
Significant dissent: 9 directors (56.5%, 54.3%, 52.5%, 51.8%, 49.6%, 49.1%, 48.6%, 37.4%, 36.2% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Tang Capital (13D, 10.0%, as of June 4, 2026)
Explore AURINIA PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are AURINIA PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 14, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Dr. Daniel Billen | 33,343,245 | -- | -- | 43,247,441 | 19,865,665 | 44% | Plurality election | — |
| Elect Director: Mr. Peter Greenleaf | 36,942,214 | -- | -- | 39,681,657 | 19,832,480 | 48.2% | Plurality election | — |
| Elect Director: Dr. David R.W. Jayne | 47,961,382 | -- | -- | 28,672,488 | 19,822,481 | 63% | Passed (calculated) | — |
| Elect Director: Mr. R. Hector MacKay-Dunn | 35,001,819 | -- | -- | 41,588,866 | 19,865,666 | 45.7% | Plurality election | — |
| Elect Director: Ms. Jill Leversage | 48,882,668 | -- | -- | 27,741,202 | 19,832,481 | 64% | Passed (calculated) | — |
| Elect Director: Dr. Brinda Balakrishnan | 36,406,544 | -- | -- | 40,184,139 | 19,865,668 | 47.5% | Plurality election | — |
| Elect Director: Dr. Karen Smith | 38,979,544 | -- | -- | 37,644,485 | 19,832,322 | 50.9% | Passed (calculated) | — |
| Elect Director: Mr. Jeffrey A. Bailey | 38,651,711 | -- | -- | 37,972,319 | 19,832,321 | 50.4% | Passed (calculated) | — |
| Elect Director: Dr. Robert T. Foster | 39,405,046 | -- | -- | 37,218,984 | 19,832,321 | 51.4% | Passed (calculated) | — |
| Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the annual general meeting of sharehol | 85,574,567 | 8,080,642 | 2,801,141 | -- | 1 | 91% | Approved | — |
| Based upon the following votes, the shareholders did not approve on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation. | 30,780,033 | 45,321,684 | 522,314 | -- | 19,832,320 | 40% | Not approved | — |
| Based upon the following votes, the shareholders did not approve the Company's Amendment to the Equity Incentive Plan. | 35,700,702 | 40,481,025 | 442,301 | -- | 19,832,323 | 46.9% | Not approved | — |
Source: AURINIA PHARMACEUTICALS INC., Form 8-K, filed with the SEC on June 14, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
170 asset managers disclosed a vote on at least one AURINIA PHARMACEUTICALS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
44% Plurality election · of votes cast
Description as filed by funds: Election of Directors: Dr. Daniel G. Billen
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dr. Daniel Billen”): 33,343,245 for, 43,247,441 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.
Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 44% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 8,592,072 for, 729,012 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 210,611 | 0 | 0 | 132,100 | Mixed |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 114,400 | 0 | 0 | 62,991 | Mixed |
| Nationwide | 121,153 | 0 | 0 | 33,649 | Mixed |
| Invesco | 0 | 0 | 0 | 81,129 | Withhold |
| MUTUAL FUND SERIES TRUST | 80,000 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 70,525 | Withhold |
| Northern Trust | 0 | 0 | 0 | 62,632 | Withhold |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,057 | 0 | 0 | 34,509 | Mixed |
| John Hancock | 0 | 0 | 0 | 47,939 | Withhold |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 42,195 | Withhold |
| ProShares | 0 | 0 | 0 | 33,732 | Withhold |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 19,755 | Withhold |
| Legg Mason | 0 | 0 | 0 | 18,794 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 16,366 | Withhold |
Showing the 25 largest of 38 asset managers. All 38 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
47.5% Plurality election · of votes cast
Description as filed by funds: Election of Directors: Dr. Brinda Balakrishnan
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dr. Brinda Balakrishnan”): 36,406,544 for, 40,184,139 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.
Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 47.5% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 8,858,458 for, 382,626 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 114,400 | 0 | 0 | 62,991 | Mixed |
| Nationwide | 121,153 | 0 | 0 | 33,649 | Mixed |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,057 | 0 | 0 | 34,509 | Mixed |
| John Hancock | 0 | 0 | 0 | 47,939 | Withhold |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 42,195 | Withhold |
| ProShares | 0 | 0 | 0 | 33,732 | Withhold |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 19,755 | Withhold |
| Legg Mason | 0 | 0 | 0 | 18,794 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 16,366 | Withhold |
| Principal | 0 | 0 | 0 | 15,837 | Withhold |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
63% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Dr. David R. W. Jayne
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dr. David R.W. Jayne”): 47,961,382 for, 28,672,488 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 63% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 9,227,630 for, 13,454 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
50.4% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jeffrey A. Bailey
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Jeffrey A. Bailey”): 38,651,711 for, 37,972,319 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 50.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 9,241,084 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
64% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jill Leversage
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Ms. Jill Leversage”): 48,882,668 for, 27,741,202 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 64% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 9,227,630 for, 13,454 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
50.9% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Dr. Karen Smith
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dr. Karen Smith”): 38,979,544 for, 37,644,485 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 50.9% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 9,241,084 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
48.2% Plurality election · of votes cast
Description as filed by funds: Election of Directors: Peter Greenleaf
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. Peter Greenleaf”): 36,942,214 for, 39,681,657 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.
Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 48.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 9,241,084 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
45.7% Plurality election · of votes cast
Description as filed by funds: Election of Directors: R. Hector MacKay-Dunn
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Mr. R. Hector MacKay-Dunn”): 35,001,819 for, 41,588,866 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.
Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 45.7% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 8,795,826 for, 445,258 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 114,400 | 0 | 0 | 62,991 | Mixed |
| Nationwide | 121,153 | 0 | 0 | 33,649 | Mixed |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 62,632 | Withhold |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 25,057 | 0 | 0 | 34,509 | Mixed |
| John Hancock | 0 | 0 | 0 | 47,939 | Withhold |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 42,195 | Withhold |
| ProShares | 0 | 0 | 0 | 33,732 | Withhold |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 19,755 | Withhold |
| Legg Mason | 0 | 0 | 0 | 18,794 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 16,366 | Withhold |
| Principal | 0 | 0 | 0 | 15,837 | Withhold |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
51.4% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Dr. Robert T. Foster
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Dr. Robert T. Foster”): 39,405,046 for, 37,218,984 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 51.4% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 9,241,084 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
46.9% Not approved · of votes cast
Description as filed by funds: Amendment to Equity Incentive Plan To approve the amendment to the Company's Equity Incentive Plan to increase the maximum number of common shares of the Company reserved for issuance pursuant to the Equity Incentive Plan, as set forth in the Company's Proxy Statement/Circular.
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: Based upon the following votes, the shareholders did not approve the Company's Amendment to the Equity Incentive Plan.”): 35,700,702 for, 40,481,025 against — failed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Not approved, in the filing’s own words: “Proposal 4: Based upon the following votes, the shareholders did not approve the Company's Amendment to the Equity Incentive Plan.”
Support: 46.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of AURINIA PHARMACEUTICALS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “To approve the amendment to the Company s Equity Incentive Plan to increase the maximum number of common shares of the Company reserved for issuance pursuant to the Equity Incentive Plan, as set forth in the Company s Proxy Statement/Circular.” (7 managers, 761,020 for); “Amendment to Equity Incentive Plan - To approve the amendment to the Company's Equity Incentive Plan to increase the maximum number of common shares of the Company reserved for issuance pursuant to the Equity Incentive Plan, as set forth in the Company's Proxy Statement/Cirular” (3 managers, 78,625 for, 34,509 against).
The 29 asset managers below reported 8,432,730 for, 13,454 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 153,506 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
| Principal | 15,837 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 13,973 | 0 | 0 | 0 | For |
| Calvert | 0 | 13,454 | 0 | 0 | Against |
| ALPS ETF Trust | 11,704 | 0 | 0 | 0 | For |
| T. Rowe Price | 8,773 | 0 | 0 | 0 | For |
| Brinker Capital Destinations Trust | 4,871 | 0 | 0 | 0 | For |
Showing the 25 largest of 29 asset managers. All 29 are in the interactive database (link above).
Combines 14 wordings of this item as funds reported it.
40% Not approved · of votes cast
Description as filed by funds: Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular.
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders did not approve on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation.”): 30,780,033 for, 45,321,684 against — failed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Not approved, in the filing’s own words: “Proposal 3: Based upon the following votes, the shareholders did not approve on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation.”
Support: 40% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of AURINIA PHARMACEUTICALS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (5 managers, 489,272 against).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 592,254 | 0 | 0 | Against |
| Equitable | 210,611 | 132,100 | 0 | 0 | Mixed |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 114,400 | 62,991 | 0 | 0 | Mixed |
| Nationwide | 119,857 | 34,945 | 0 | 0 | Mixed |
| Invesco | 0 | 81,129 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 80,000 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 0 | 70,525 | 0 | 0 | Against |
| Northern Trust | 0 | 62,632 | 0 | 0 | Against |
| Global X | 0 | 60,419 | 0 | 0 | Against |
| Bridge Builder Trust | 25,057 | 34,509 | 0 | 0 | Mixed |
| John Hancock | 0 | 47,939 | 0 | 0 | Against |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 42,195 | 0 | 0 | Against |
| ProShares | 0 | 33,732 | 0 | 0 | Against |
| SEI | 0 | 26,400 | 0 | 0 | Against |
| DWS | 0 | 19,755 | 0 | 0 | Against |
| Legg Mason | 0 | 18,794 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 16,366 | 0 | 0 | Against |
Fund voting reports, all 37 managers: 7,911,703 for, 1,407,985 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 7,209,884 | 0 | 0 | 0 | For |
| NEA Management Company, LLC | 3,969,834 | 0 | 0 | 0 | For |
| BlackRock | 2,419,097 | 92,814 | 0 | 0 | For |
| Nuveen | 2,041,437 | 0 | 0 | 0 | For |
| State Street | 1,504,074 | 38,935 | 0 | 0 | For |
| Goldman Sachs | 1,051,693 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 975,975 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 844,109 | 0 | 0 | Against |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0 | 734,122 | 0 | 0 | Against |
| Charles Schwab | 0 | 592,254 | 0 | 0 | Against |
| 683 Capital Management, LLC | 0 | 585,000 | 0 | 0 | Against |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 557,765 | 0 | 0 | Against |
| Woodline Partners LP | 467,424 | 0 | 0 | 0 | For |
| Vanguard | 329,181 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 0 | 247,052 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 215,833 | 0 | 0 | Against |
| STATE OF WISCONSIN INVESTMENT BOARD | 0 | 204,404 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 183,592 | 0 | 0 | 0 | For |
| Hudson Bay Capital Management LP | 0 | 154,635 | 0 | 0 | Against |
| UBS | 0 | 138,555 | 0 | 0 | Against |
| Invesco | 0 | 137,653 | 0 | 0 | Against |
| AllianceBernstein | 0 | 135,500 | 0 | 0 | Against |
| FRANKLIN ADVISERS INC | 0 | 81,785 | 0 | 0 | Against |
| ROCKEFELLER FINANCIAL LLC | 80,665 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 77,520 | 0 | 0 | Against |
Institutional-manager reports, all 141 managers: 20,520,299 for, 5,847,406 against, 1,140 abstained, 18,935 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
91% Approved · of votes cast
Description as filed by funds: Appointment of Auditors Appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm until the close of the 2025 annual general meeting of shareholders or until a successor its appointed.
AURINIA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm unti”): 85,574,567 for, 8,080,642 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the annual general meeting of shareholders to be held in 2025 or until a succ…”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 9,319,688 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,922,395 | 0 | 0 | 0 | For |
| TIAA | 2,036,756 | 0 | 0 | 0 | For |
| Vanguard | 1,210,719 | 0 | 0 | 0 | For |
| Goldman Sachs | 601,606 | 0 | 0 | 0 | For |
| Charles Schwab | 592,254 | 0 | 0 | 0 | For |
| Equitable | 342,711 | 0 | 0 | 0 | For |
| Fidelity | 246,509 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 208,717 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,391 | 0 | 0 | 0 | For |
| Nationwide | 154,802 | 0 | 0 | 0 | For |
| Invesco | 81,129 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 80,000 | 0 | 0 | 0 | For |
| State Street | 77,881 | 0 | 0 | 0 | For |
| Voya | 70,525 | 0 | 0 | 0 | For |
| Northern Trust | 62,632 | 0 | 0 | 0 | For |
| Global X | 60,419 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 59,566 | 0 | 0 | 0 | For |
| John Hancock | 47,939 | 0 | 0 | 0 | For |
| Pacific Life | 43,511 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 42,195 | 0 | 0 | 0 | For |
| ProShares | 33,732 | 0 | 0 | 0 | For |
| SEI | 26,400 | 0 | 0 | 0 | For |
| DWS | 19,755 | 0 | 0 | 0 | For |
| Legg Mason | 18,794 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 16,366 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. All 37 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 143,690,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.03% |
| 2 | TIAA | 1.42% |
| 3 | Vanguard | 0.84% |
| 4 | Goldman Sachs | 0.42% |
| 5 | Charles Schwab | 0.41% |
| 6 | Equitable | 0.24% |
| 7 | Fidelity | 0.17% |
| 8 | QUANTITATIVE MASTER SERIES LLC | 0.15% |
| 9 | Lincoln Financial | 0.12% |
| 10 | Nationwide | 0.11% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARMISTICE CAPITAL, LLC | 5.02% |
| 2 | NEA Management Company, LLC | 2.76% |
| 3 | BlackRock | 1.75% |
| 4 | Nuveen | 1.42% |
| 5 | State Street | 1.07% |
| 6 | Goldman Sachs | 0.73% |
| 7 | Rock Springs Capital Management LP | 0.68% |
| 8 | Northern Trust | 0.59% |
| 9 | SCHRODER INVESTMENT MANAGEMENT GROUP | 0.51% |
| 10 | Charles Schwab | 0.41% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 7,448,858 | 5.18% | Form 13F, quarter ended March 31, 2024 |
| State Street | 2,770,864 | 1.93% | Form 13F, quarter ended March 31, 2024 |
| Nuveen | 2,059,107 | 1.43% | Form 13F, quarter ended March 31, 2024 |
| Morgan Stanley | 1,946,785 | 1.35% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 1,603,080 | 1.12% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 1,557,509 | 1.08% | Form 13F, quarter ended March 31, 2024 |
| Northern Trust | 1,022,792 | 0.71% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 842,027 | 0.59% | Form 13F, quarter ended March 31, 2024 |
| Citadel Advisors | 728,803 | 0.51% | Form 13F, quarter ended March 31, 2024 |
| Charles Schwab | 538,958 | 0.38% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 143,690,000 shares outstanding, as reported by AURINIA PHARMACEUTICALS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At AURINIA PHARMACEUTICALS INC.'s shareholder meeting held June 14, 2024, in the 2023-2024 proxy season, 170 asset managers reported votes on at least one of its 12 ballot items in their SEC Form N-PX filings, covering 1,398 separate fund positions. On the most widely held item on that ballot — Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, a… — AURINIA PHARMACEUTICALS INC.'s filing reports the proposal as not approved, with 40% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AURINIA PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 14, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AURINIA PHARMACEUTICALS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
AURINIA PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “AURINIA PHARMACEUTICALS (AUPH) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/aurinia-pharmaceuticals-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.